Brief: Hofseth Biocare Q4 operating loss narrows to NOK 18.5 million
Feb 15 (Reuters) - Hofseth Biocare ASA HOFBC.OL :
* Q4 operating revenue 3.1 million Norwegian crowns ($370,601) versus 26.7 million crowns
year ago
* Q4 operating loss 18.5 million crowns versus loss 39.9 million crowns year ago
Source text for Eikon: ID:nGNE62k3Cm
Further company coverage: HOFBC.OL
($1 = 8.3648 Norwegian crowns)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering